News
-
15 August 2018
Industry Viewpoints: Effectively Outsourcing Early Phase Clinical Trials
CTA’s Elizabeth Williams catches up with Jeffrey Hausfeld, CMO, BioFactura, on the complexities of carrying out early phase studies
-
13 August 2018
Considerations for Manufacturing Investigational Medicinal Products for Clinical Studies
Kavita Vermani, Adamas Pharmaceuticals, Inc., explains the considerations required for the manufacture and release of investigational drug products
-
9 August 2018
How to Maximize Randomization and Trial Management Systems in Clinical Studies
Francesco Spoto, Clinical Study Expert, highlights the advantages of using IRT solutions for pharma's SMEs and the best strategies to reap its benefits
-
7 August 2018
Tech Giants Tackle Health Care: An Opportunity or Threat for the Pharmaceutical Industry?
CTA’s Anne-Marie Mongan explores whether the tech industry’s foray into health care is a benefit or hindrance to the industry
-
6 August 2018
Social Media and Clinical Trials – Is the Hype all it’s made out to be?
CTA’s Charlie Abrines speaks to Adrian Orr, Director, Clinical Affairs, Anika Therapeutics, about the role social media can play in patient recruitment
-
3 August 2018
The Top 5: July 2018
CTA highlights the best articles from the month of July 2018
-
1 August 2018
Immuno-Oncology and Combination Trials: New Aspirations, Old Frustrations
Ramani A. Aiyer, Shasta BioVentures, explores the immuno-oncology landscape, shining a spotlight on the promise immunotherapy holds for the future
-
31 July 2018
Biopharmaceuticals and the DACH Region: The Availability of Patients in Austria, Germany and Switzerland
CTA’s Adeola Coker explores why patient recruitment remains a challenge in the DACH region
-
30 July 2018
Expert Insights: The Future of Drug Discovery Looks to be in the Hands of Artificial Intelligence
In her latest Expert Insight, Alexandra Annis, MS, Senior Immunology Analyst, GlobalData, ponders the role of AI in clinical trials
-
24 July 2018
Enriched Evidence Generation: Linking Clinical Data, Registries and Patient-Reported Outcomes to Health Care Utilization
Eric Van Ganse, Manon Belhassen, PELyon, & Francois Gavini, Roche, explain how French national claims data can deliver critical value to clinical trials and patients registries
